Veterinary pharma company spun off from Pfizer.

Updates from The Motley Fool

Latest updates on Zoetis from

Americans are spending more money on their pets than ever before -- and that's been good news for...

2 Stocks Bill Ackman Is Dumping

Photo by: Getty Images. Bill Ackman's Pershing Square Capital Management has seen better days. Th...

8 Top Stocks Billionaires Love

Google's parent company, Alphabet, is a popular billionaire stock pick. Image source: Google. Inv...

The Fool Looks Ahead

There's never a dull week on Wall Street. Let's go over some of the news that will shape the week...

Stock Performance

View Interactive ZTS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Zoetis.
Current Price: $51.03
Prev Close: $50.94
Open: $51.06
Bid: $50.38
Ask: $51.99
Day's Range: $50.81 - $51.19
52wk Range: $38.26 - $53.14
Volume: 1,674,033
Avg Vol 3,274,290
Market Cap: $25B
P/E (ttm): 39.49
EPS (ttm): $1.29
Div & Yield: $0.38 (0.7%)

Company Rating

What our community thinks about Zoetis.
CAPS Rating 4 out of 5
117 Outperform
5 Underperform
CAPS All Stars
26 Outperform
0 Underperform

How do you think Zoetis will perform against the market?

You pick for Zoetis is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS

CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Juan Ramon Alaix, CEO

65% Approve

Based on 57 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Zoetis.

Veterinary pharma company spun off from Pfizer.

  • Exchange: NYSE